)
Neurogene (NGNE) investor relations material
Neurogene Guggenheim Securities Emerging Outlook: Biotech Summit 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and lead program
Focuses on genetic medicines for rare neurologic diseases using a biology-first approach.
Lead program NGN-401 targets Rett syndrome, a multi-billion dollar market with 15,000–20,000 patients in the US and Europe.
NGN-401 pivotal study began dosing in Q4 2025, with enrollment and dosing completion expected in Q2 2026.
Phase I/II data showed 35 milestones gained across 8 participants, indicating multi-domain, durable improvements.
Upcoming catalyst is the completion of enrollment and 12-month data readout for all 10 patients in mid-2026.
Differentiation and technology
NGN-401 uses a full-length human MECP2 gene and proprietary technology to regulate expression, minimizing toxicity.
Delivery method ensures drug reaches neurons in the brain, addressing the root cause of Rett syndrome.
Route of administration (ICV) is supported by caregivers, KOLs, and payers, who prioritize efficacy over delivery concerns.
Payers focus on clear, objective efficacy endpoints, such as milestone gains.
Safety, dosing, and monitoring
Previous HLH event at higher dose (3E15); current pivotal dose (1E15) is three times lower and has shown no HLH cases.
Monitoring protocol includes ferritin and other immune markers for early detection and reversibility of adverse events.
Nerve conduction issues observed were transient and align with known AAV gene therapy class effects.
Safety updates will be disclosed if material events occur; current data shows no new safety concerns.
Next Neurogene earnings date
Next Neurogene earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)